Sort
15,273 grants matching “antimicrobial resistance”
Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
$801,759Lisa Saiman · Columbia University Health Sciences · R01 · FY2008 · NR
Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications
$801,696Alexander Keith Wolf · Nota Laboratories, Llc · R44 · FY2023 · HL
Foam cells as drug targets in tuberculosis
$801,457Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2019 · HL
Drug resistance enablers and their role in antibiotic treatment failure
$800,994Vaughn Cooper · Boston Children'S Hospital · U19 · FY2025 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$800,065Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2022 · AI
ALTERNATIVES TO ANTIBIOTICS IN ANIMAL AGRICULTURE: IMPACTS ON ANTIMICROBIAL RESISTANCE OF ENTERIC BACTERIA
$800,000Kansas State University · · FY2013 · National Institute of Food and Agriculture
Stress Response Mechanisms in Vibrio
$800,000Jyl S Matson · University Of Toledo Health Science Campus · · FY2022 · BIO
Novel Drug Discovery against P. falciparum ENR
$799,998Texas Agrilife Research · P01 · FY2005 · AI
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
$799,990Richard Platt · Harvard Pilgrim Health Care, Inc. · U54 · FY2015 · CK
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network
$799,984Ebbing Lautenbach · University Of Pennsylvania · U54 · FY2015 · CK
EFFECTIVE INTERVENTIONS TO PREVENT EMERGENCE AND DISSEMINATION OF ANTIMICROBIAL RESISTANCE AT THE POPULATION, ANIMAL, AND MICROBIAL LEVELS
$799,958Ohio State University, The · · FY2013 · National Institute of Food and Agriculture
Host-pathogen interactions during hospital adaptation of MRSA
$799,626Bo Shopsin · New York University School Of Medicine · R01 · FY2022 · AI
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections
$799,513Deverick John Anderson · Duke University · U54 · FY2017 · CK
Obstetric Pharmacology Research Units Network Center at UTMB-Galveston
$799,355Gary D Hankins · University Of Texas Med Br Galveston · U10 · FY2012 · HD
Novel Drug Discovery against P. falciparum ENR
$799,236Texas Agrilife Research · P01 · FY2004 · AI
EpiModel 2.0: Integrated Network Models for HIV/STI Prevention Science
$799,074Samuel Jenness · Emory University · R01 · FY2018 · AI
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$798,954Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2022 · AI
Structure-based microbially targeted prodrugs
$798,784Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI
Chemically modified minocycline for treatment of alcohol use disorder
$798,758Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2019 · AA
A cross protective multivalent vaccine for Shigella and ETEC
$798,505David A Sack · Johns Hopkins University · R01 · FY2023 · AI
An immunotherapeutic to prevent gonorrhea
$798,475Keith Wycoff · Planet Biotechnology, Inc. · R44 · FY2020 · AI
Chicago Prevention and Intervention Epicenter (Chicago PIE)
$798,269Robert Alan Weinstein · Hektoen Institute For Medical Research · U54 · FY2015 · CK
The Effects of Doxycycline on Inflammation and the Microbiome: 'Flipping the Script' on STI PEP
$797,734Colleen F Kelley · Emory University · R01 · FY2025 · AI
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis
$797,700Xin-Xing Xing Gu · National Institute On Deafness And Other Communication Disorders · Z01 · FY2008 · DC
Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections
$797,454Amanda M Jamieson · Brown University · R01 · FY2023 · HL